
Overview
William E. Spielvogle, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center at UPMC Horizon. He specializes in all areas of general oncology, and has a clinical interest in breast cancer.
Dr. Spielvogle is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Lynch Syndrome, and Thrombocytopenia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2200 Memorial Drive, Farrell, PA 16121
University Of Pittsburgh Physicians
Jason Luke is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Luke is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, and Liver Embolization.
UPMC Hillman Cancer Center
John M. Kirkwood, MD, is a professor of medicine, dermatology, and clinical and translational science at the University of Pittsburgh School of Medicine and the Clinical and Translational Science Institute at the University of Pittsburgh. Dr. Kirkwood directs the Melanoma Center at UPMC Hillman Cancer Center and specializes in melanoma research and the prevention and early detection of melanoma, as well as the treatment of advanced disease and adjuvant therapy of resectable disease. Dr. Kirkwood is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Uveal Melanoma.
UPMC Hillman Cancer Center
Yana G. Najjar, MD is a translational investigator and cutaneous oncologist at UPMC Hillman Cancer Center, where she also is an associate professor of medicine and Director of the Clinical and Translational Research Center. Dr. Najjar specializes in early phase clinical trials and in the treatment of advanced melanoma. Her research focusing on immunotherapy resistant melanoma and rare melanoma subtypes. She has developed multiple investigator-initiated trials that aim to remodel melanoma tumor cell metabolism and hypoxia in the tumor microenvironment to overcome mechanisms of resistance to immunotherapy. Her lab is focused on various correlative analyses from investigator-initiated trials. Dr. Najjar's research is funded by the NIH, the Department of Defense, and the Melanoma Research Alliance. Dr. Najjar is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC), and Gamma Knife Radiosurgery.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AnemiaDr. Spielvogle isDistinguished. Learn about Anemia.
- AngiosarcomaDr. Spielvogle isDistinguished. Learn about Angiosarcoma.
- Lung AdenocarcinomaDr. Spielvogle isDistinguished. Learn about Lung Adenocarcinoma.
- Lynch SyndromeDr. Spielvogle isDistinguished. Learn about Lynch Syndrome.
- Paget Disease of the BreastDr. Spielvogle isDistinguished. Learn about Paget Disease of the Breast.
- Small Cell Lung Cancer (SCLC)Dr. Spielvogle isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- Acute Mountain SicknessDr. Spielvogle isAdvanced. Learn about Acute Mountain Sickness.
- AgranulocytosisDr. Spielvogle isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Spielvogle isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Breast CancerDr. Spielvogle isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Spielvogle isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Spielvogle isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Spielvogle isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Eosinophilic PneumoniaDr. Spielvogle isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Spielvogle isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with MaturationDr. Spielvogle isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Spielvogle isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Spielvogle isExperienced. Learn about Acute Myeloid Leukemia (AML).



